Category: Latest News

  • Redhill Biopharma Shares Surge 28% After FDA Signals Positive Approval Path for Crohn’s Drug

    Redhill Biopharma Shares Surge 28% After FDA Signals Positive Approval Path for Crohn’s Drug

    Redhill Biopharma Ltd (NASDAQ:RDHL) stock soared 28% following encouraging feedback from the U.S. Food and Drug Administration (FDA) on the approval pathway for its RHB-204 program targeting Crohn’s disease. The FDA’s guidance permits Redhill to launch the first clinical trial focusing on a specific subgroup of Crohn’s patients infected with Mycobacterium avium subspecies paratuberculosis (MAP-positive).…

  • Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq

    Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq

    Connect Biopharma Holdings Ltd (NASDAQ:CNTB) saw its stock jump 6.4% after announcing its intention to terminate its American Depositary Receipts (ADR) program and directly list its ordinary shares on the Nasdaq Global Market. The company plans to end its Deposit Agreement with Deutsche Bank Trust Company Americas around September 2, 2025. At that time, all…

  • Bon Natural Life Shares Rise Following $22 Million Distribution Agreement

    Bon Natural Life Shares Rise Following $22 Million Distribution Agreement

    Bon Natural Life Ltd (NASDAQ:BON) saw its stock climb 4.6% after announcing a new non-exclusive sales distribution deal with Beijing Huahai Keyuan Technology Co. Ltd. The three-year agreement, valued at $22 million, will allow Huahai Keyuan to distribute Bon Natural Life’s natural weight management products across China and Southeast Asia. The product line incorporates a…

  • Lam Research Stock Climbs to 52-Week Peak at $102.32

    Lam Research Stock Climbs to 52-Week Peak at $102.32

    Lam Research Corp (NASDAQ:LRCX) has reached a new 52-week high, with shares hitting $102.32, marking a significant milestone for the semiconductor equipment giant valued at $130.34 billion. This uptick reflects steady growth and strong investor confidence, as the company’s stock has gained 4.54% over the past year, underscoring its robust market position. Lam Research has…

  • Autonomix Medical Shares Jump 13% Following Smart Torquer Patent Approval

    Autonomix Medical Shares Jump 13% Following Smart Torquer Patent Approval

    Autonomix Medical Inc (NASDAQ:AMIX) saw its stock climb 13% after the medical device firm announced it received a patent from the U.S. Patent and Trademark Office for its innovative “Smart Torquer” technology. The newly granted patent (No. 12,295,646) protects a smart torquer device engineered to improve the handling of intravascular instruments during minimally invasive procedures,…

  • Bit Origin Shares Rally 12% Following Strategic Acquisition of 40.5 Million Dogecoin

    Bit Origin Shares Rally 12% Following Strategic Acquisition of 40.5 Million Dogecoin

    Shares of Bit Origin Ltd (NASDAQ:BTOG) surged 12% after the company revealed its initial strategic purchase of approximately 40.5 million Dogecoin (DOGE) as part of a broader digital asset treasury plan. This acquisition marks the first step in Bit Origin’s previously announced capital facility program, which allows for investments up to $500 million. The company…

  • Cerus Shares Rise After DoD Awards Additional $7.2M for Trauma Blood Product Development

    Cerus Shares Rise After DoD Awards Additional $7.2M for Trauma Blood Product Development

    Cerus Corporation (NASDAQ:CERS) saw its stock climb 3.3% following news of a $7.2 million contract amendment from the U.S. Department of Defense (DoD). The new funding expands the company’s existing partnership with the DoD to advance development of its lyophilized, pathogen-reduced Cryoprecipitated Fibrinogen Complex (LyoIFC). This latest award builds upon nearly $18 million previously allocated…

  • Elevance Health Shares Touch 52-Week Low Amid Sector Headwinds and Medicaid Pressures

    Elevance Health Shares Touch 52-Week Low Amid Sector Headwinds and Medicaid Pressures

    Shares of Elevance Health Inc. (NYSE:ELV) dropped to a new 52-week low of $275.60, reflecting a turbulent year for the healthcare insurer as it grapples with operational challenges and macroeconomic pressures. Despite a market cap of $62.8 billion and a price-to-earnings ratio of 11.85 suggesting the stock may be undervalued relative to its estimated fair…

  • Sequans Communications Shares Rally After Adding Over $150M in Bitcoin to Treasury

    Sequans Communications Shares Rally After Adding Over $150M in Bitcoin to Treasury

    Shares of Sequans Communications S.A. (NYSE:SQNS) climbed 6.9% after the semiconductor firm disclosed a substantial addition to its Bitcoin holdings, signaling an expanded commitment to cryptocurrency as a treasury reserve asset. The company announced that it recently acquired 1,264 Bitcoin for about $150 million, with an average purchase price of approximately $118,659 per coin, including…

  • BTCS Shares Jump After Securing $10M Convertible Note Deal to Boost Ethereum Strategy

    BTCS Shares Jump After Securing $10M Convertible Note Deal to Boost Ethereum Strategy

    Shares of BTCS Inc (NASDAQ:BTCS) soared 11% after the blockchain-focused firm announced a $10 million convertible note financing agreement with ATW Partners LLC, further reinforcing its aggressive Ethereum investment strategy. The company said the newly arranged funding adds to its liquidity reserves, pushing the combined market value of its Ethereum holdings, cash, and other liquid…